Literature DB >> 29705868

New Hope for Treatment of Duchene Dystrophy by Employing Dystrophin Expressing Chimeric Cells - Studies Published in Stem Cell Reviews and Reports.

Mariusz Z Ratajczak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29705868     DOI： 10.1007/s12015-018-9818-9

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN： 2629-3277            Impact factor:   5.739


× No keyword cloud information.
  4 in total

Review 1.  Progress toward Gene Therapy for Duchenne Muscular Dystrophy.

Authors:  Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2017-04-15       Impact factor: 12.910

Review 2.  Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity.

Authors:  Gopi Suresh Oggu; Shyama Sasikumar; Nirosha Reddy; Kranthi Kiran Reddy Ella; Ch Mohan Rao; Kiran Kumar Bokara
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 6.692

3.  Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.

Authors:  M Siemionow; J Cwykiel; A Heydemann; J Garcia-Martinez; K Siemionow; E Szilagyi
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

4.  Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.

Authors:  Maria Siemionow; Joanna Cwykiel; Ahlke Heydemann; Jesus Garcia; Enza Marchese; Krzysztof Siemionow; Erzsebet Szilagyi
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739
  4 in total
  1 in total

1.  The use of umbilical cord-derived mesenchymal stem cells in patients with muscular dystrophies: Results from compassionate use in real-life settings.

Authors:  Beata Świątkowska-Flis; Izabela Zdolińska-Malinowska; Dominika Sługocka; Dariusz Boruczkowski
Journal:  Stem Cells Transl Med       Date:  2021-07-27       Impact factor: 6.940
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.